Immunoglobulins, Intravenous

• 

  Subject Areas on Research

  • 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. 
  • 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. 
  • A Case of Probable Multifocal Motor Neuropathy With Clinical Stability for Ten Years After a Single Treatment of Rituximab. 
  • A Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus Infection. 
  • A case of atypical, complete DiGeorge syndrome without 22q11 mutation. 
  • A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. 
  • A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency. 
  • A population-based analysis on the use of therapeutic plasma exchange and intravenous immunoglobulin in heparin-induced thrombocytopenia. 
  • ADA2 deficiency (DADA2) associated with Evans syndrome and a severe ADA2 genotype. 
  • Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG). 
  • Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. 
  • Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work? 
  • Antibody desensitization therapy in highly sensitized lung transplant candidates. 
  • Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? 
  • Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. 
  • B cell loss leading to remission in severe systemic lupus erythematosus. 
  • Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. 
  • Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort. 
  • Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease. 
  • Breakthroughs in the understanding and therapy of primary immunodeficiency. 
  • CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease. 
  • Case-control study of thromboembolic events associated with IV immunoglobulin. 
  • Cerebral sinus thrombosis in a patient with humoral immunodeficiency on intravenous immunoglobulin therapy: a case report. 
  • Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash. 
  • Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita. 
  • Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. 
  • Clostridium Difficile Infection from a Surgical Perspective. 
  • Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations. 
  • Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. 
  • Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults. 
  • Comèl-Netherton syndrome defined as primary immunodeficiency. 
  • Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis. 
  • Coronary artery thickening with mucosal lesions in Henoch-Schönlein purpura. 
  • Current challenges and opportunities in the management of antibody-mediated rejection in lung transplantation. 
  • Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. 
  • Cytomegalovirus Screening in Pregnancy: A Cost-Effectiveness and Threshold Analysis. 
  • Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir. 
  • Diagnosis and antenatal management of congenital cytomegalovirus infection. 
  • Distal acquired demyelinating symmetric neuropathy after vaccination. 
  • Does IVIg administration yield improved immune function in very premature neonates? 
  • Early predictors of rapidly evolving multiple sclerosis: A case report. 
  • Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood. 
  • Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies. 
  • Efficacy of intravenous gamma globulin in autoimmune-mediated pediatric blood dyscrasias. 
  • Efficacy of intravenous immunoglobulin in Landau-Kleffner syndrome. 
  • Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. 
  • Evaluation of the Financial and Health Burden of Infants at Risk for Respiratory Syncytial Virus. 
  • Evidence-based management of bullous pemphigoid. 
  • Fever, Joint Pain, Seizures, and Rash in a 53-Year-Old Woman. 
  • Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases. 
  • Fulminant demyelinating neuropathy mimicking cerebral death. 
  • Gestational Alloimmune Liver Disease: A Case Study. 
  • Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. 
  • HLA- and genotype-based risk assessment model to identify infantile onset pompe disease patients at high-risk of developing significant anti-drug antibodies (ADA). 
  • Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience. 
  • Heterogeneity of phenotype in two siblings with adenosine deaminase deficiency. 
  • High dose IVIG successfully reduces high rhGAA IgG antibody titers in a CRIM-negative infantile Pompe disease patient. 
  • High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. 
  • Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition. 
  • IVIG in Landau-Kleffner syndrome. 
  • IVIG therapy in neonatal isoimmune thrombocytopenic purpura and alloimmunization thrombocytopenia. 
  • Immune Modulation for Enzyme Replacement Therapy in A Female Patient With Hunter Syndrome. 
  • Immune globulin subcutaneous, human - klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study. 
  • Immune-related Neurological Symptoms in an Adolescent Patient Receiving the Checkpoint Inhibitor Nivolumab. 
  • Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease. 
  • Immunotherapy for refractory pulmonary infection after adult cardiac surgery: immune dysregulation syndrome. 
  • Immunotherapy in selected patients with Down syndrome disintegrative disorder. 
  • Individualized immunoglobulin treatment in pediatric patients with primary humoral immunodeficiency disease. 
  • Inflammatory pulmonary nodules in Kawasaki disease. 
  • International consensus guidance for management of myasthenia gravis: Executive summary. 
  • Intestine Transplantation Across a Positive Crossmatch With Preformed Donor-Specific Antibodies. 
  • Intravenous immunoglobulin G improves neurobehavioral and histological outcomes after traumatic brain injury in mice. 
  • Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. 
  • Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation. 
  • Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. 
  • Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature. 
  • Intravenous versus subcutaneous immunoglobulin - Authors' reply. 
  • Isolated IgA deficiency after chemotherapy for acute myelogenous leukemia in an infant. 
  • Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. 
  • Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. 
  • Juvenile dermatomyositis: recognition and treatment. 
  • Lambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients. 
  • Landau-Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report. 
  • Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: inadequacy of current dosage practices and approaches to the problem. 
  • MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. 
  • Management of Landau-Kleffner syndrome. 
  • Management of immune dysfunction after adult cardiac surgery. 
  • Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model. 
  • Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases. 
  • Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management. 
  • Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy. 
  • Pericarditis mediated by respiratory syncytial virus in a hematopoietic stem cell transplant patient. 
  • Persistent and Prolonged Parvovirus B19 Viremia in a Pediatric Patient With Acute Lymphoblastic Leukemia. 
  • Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%). 
  • Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency. 
  • Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer. 
  • Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study. 
  • Potential Confounding of Diagnosis of Rabies in Patients with Recent Receipt of Intravenous Immune Globulin. 
  • Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors. 
  • Prevention and treatment of nosocomial sepsis in the NICU. 
  • Prevention of hyperacute xenograft rejection by intravenous immunoglobulin. 
  • Primary Immune Deficiency: Patients' Preferences for Replacement Immunoglobulin Therapy. 
  • Primary immunodeficiency or not? Making the correct diagnosis. 
  • Prophylactic IVIG and corticosteroids for severe skin reactions post radio-contrast. 
  • Prophylaxis of cytomegalovirus disease in allogeneic bone marrow transplantation. 
  • Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. 
  • Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. 
  • Rapid infusion of Sandoglobulin in patients with primary humoral immunodeficiency. 
  • Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts. 
  • Reduction in transplant-related complications in patients given intravenous immuno globulin after allogeneic marrow transplantation. 
  • Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. 
  • Responding to the immunoglobulin shortage: a case study. 
  • Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study. 
  • Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study. 
  • Secondary immunodeficiencies and stem cell transplantation: issues of administration and safety of intravenous immunoglobulin. 
  • Severe primary refractory thrombotic thrombocytopenic purpura (TTP) in the post plasma exchange (PEX) and rituximab era. 
  • Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection. 
  • Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. 
  • Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States. 
  • Subcutaneous immunoglobulin replacement therapy with Hizentra, the first 20% SCIG preparation: a practical approach. 
  • Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome. 
  • Susac syndrome with transient inverted vision. 
  • Systemic IgG exposure and safety in patients with primary immunodeficiency: a randomized crossover study comparing a novel investigational wearable infusor versus the Crono pump. 
  • The potential impact of timing of IVIG administration on the efficacy of rituximab for immune tolerance induction for patients with Pompe disease. 
  • The potential of xenotransplants. 
  • The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. 
  • The top clinical trial opportunities in therapeutic apheresis and neurology. 
  • The treatment of patients with myasthenia gravis. 
  • The uses of intravenous immunoglobulin in pediatrics. An update. 
  • Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review. 
  • Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis. 
  • Tolerability of a new 10% liquid immunoglobulin for intravenous use, Privigen, at different infusion rates. 
  • Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey. 
  • Treatment of platelet alloimmunization with intravenous immunoglobulin. Two case reports and review of the literature. 
  • Unexplained regression in Down syndrome: Management of 51 patients in an international patient database. 
  • Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis. 
  • Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion. 
  • Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage. 
  • Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. 
  • Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. 
  • Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. 
  • Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms. 
  • What is the significance of gender difference in myasthenia gravis? 
• 

  Keywords of People

  • Buckley, Rebecca Hatcher, James Buren Sidbury Distinguished Professor Emeritus of Pediatrics, in the School of Medicine, Pediatrics, Allergy and Immunology